Accelerate BC

Accelerated Biosciences (ABC) is a private regenerative medicine company focused on the development and commercialization of human Trophoblast Stem Cells (hTSCs). The company's proprietary hTSC platform provides a source of pluripotent-like stem cells that are ethically sourced, immune-privileged, and capable of large-scale expansion without the genetic instability often seen in other stem cell types. ABC leverages these cells for diverse applications, including the development of off-the-shelf cell therapies, drug discovery, and toxicology testing. By providing a robust and scalable cell source, the company aims to accelerate the delivery of next-generation treatments for oncology, inflammatory conditions, and degenerative diseases.